CEO, CROWN STERLING
WHY: Involved with healthcare, technology, and security companies over the past two decades. Exec roles at Allergan, others. Backer of Botox competitor Evolus and newly unveiled drug firm Aeon Biopharma.
RECENT: Took wraps off Crown Sterling’s Time AI algorithm, said to have ability to hack a 250-bit encryption in under a minute—a feat supercomputers cannot achieve—in September 2019.
NOTABLE: Former CEO and president of Bausch & Lomb Surgical, chairman at Biolase. MBA, Thunderbird School of Global Management at Arizona State University.
